drugset
drugset / Trial / NCT01661738

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002

NCT01661738 ↗

Phase 2 Completed 360 enrolled Hualan Biological Engineering, Inc.
NaSingle-groupOpen-labelPrevention

Summary

The clinical trial was designed to evaluate the safety and immunogenicity against Group ACYW135 Meningococcal Polysaccharide Vaccine of Hualan administered on subjects 2 years of age and older.

Timeline

Start
2006-05
Primary completion
2006-05
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Group ACYW135 Meningococcal Polysaccharide Vaccine Vaccine 0.5 ml —

Indications

meningitis